HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: CJN.00010505v1 1/1/70    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, D. Y. Articles by Kalantar-Zadeh, K. Search for Related Content PubMed PubMed Citation Articles by Wu, D. Y. Articles by Kalantar-Zadeh, K.

Association between Serum Bicarbonate and Death in Hemodialysis Patients: Is It Better to Be Acidotic or Alkalotic?

Dennis Y. Wu^*, Christian S. Shinaberger^*,, Deborah L. Regidor^*,, Charles J. McAllister, Joel D. Kopple^*, and Kamyar Kalantar-Zadeh^*

^* Division of Nephrology and Hypertension, Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance, California; School of Public Health, University of California, Los Angeles, Los Angeles, California; and DaVita, Inc., El Segundo, California

Address correspondence to: Dr. Kamyar Kalantar-Zadeh, Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, C1-Annex, Torrance, CA 90502-2064. Phone: 310-222-3891; Fax: 310-782-1837; E-mail: kamkal{at}ucla.edu

The optimal acid-base status for survival in maintenance hemodialysis (MHD) patients remains controversial. According to recent reports, acidosis is associated with improved survival in MHD patients. It was hypothesized that this inverse association is due to a confounding effect of the malnutrition-inflammation complex syndrome (MICS). Associations between baseline (first 3 mo averaged) predialysis serum bicarbonate (HCO₃^–) and 2-yr mortality were examined in 56,385 MHD patients who were treated in virtually all DaVita dialysis clinics across the United States. The range of HCO₃^– was divided into 12 categories (<17, 27, and 10 groups in between). Three sets of Cox regression models were evaluated to estimate hazard ratios of all-cause and cardiovascular death in both incident and prevalent patients: (1) Unadjusted, (2) multivariate case mix adjusted (which also included dialysate HCO₃^– and Kt/V), and (3) adjusted for case mix and nine markers of MICS (body mass index; erythropoietin dose; protein intake; serum albumin; creatinine; phosphorus; calcium; ferritin and total iron binding capacity; and blood hemoglobin, WBC, and lymphocytes). There were significant inverse associations between serum HCO₃^– and serum phosphorus and estimated protein intake. The lowest unadjusted mortality was associated with predialysis HCO₃^– in the 17- to 23-mEq/L range, whereas values 23 mEq/L were associated with progressively higher all-cause and cardiovascular death rates. This association, however, reversed after case-mix and MICS multivariate adjustment, so that HCO₃^– values >22 mEq/L had lower death risk. Although previous epidemiologic studies indicated an association between high serum HCO₃^– and increased mortality in MHD patients, this effect seems to be due substantially to the effect of MICS on survival.

This article has been cited by other articles:

				C. P. Kovesdy, D. L. Regidor, R. Mehrotra, J. Jing, C. J. McAllister, S. Greenland, J. D. Kopple, and K. Kalantar-Zadeh Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 999 - 1007. [Abstract] [Full Text] [PDF]